163 related articles for article (PubMed ID: 32705569)
1. The NIMH 'Fast-Fail Trials' (FAST) Initiative: Rationale, Promise, and Progress.
Grabb MC; Hillefors M; Potter WZ
Pharmaceut Med; 2020 Aug; 34(4):233-245. PubMed ID: 32705569
[TBL] [Abstract][Full Text] [Related]
2. Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial.
Javitt DC; Carter CS; Krystal JH; Kantrowitz JT; Girgis RR; Kegeles LS; Ragland JD; Maddock RJ; Lesh TA; Tanase C; Corlett PR; Rothman DL; Mason G; Qiu M; Robinson J; Potter WZ; Carlson M; Wall MM; Choo TH; Grinband J; Lieberman JA
JAMA Psychiatry; 2018 Jan; 75(1):11-19. PubMed ID: 29167877
[TBL] [Abstract][Full Text] [Related]
3. CNS drug development: lessons learned part 2. Symptoms, not syndromes as targets consistent with the NIMH research domain approach.
Preskorn SH
J Psychiatr Pract; 2015 Jan; 21(1):60-6. PubMed ID: 25603452
[TBL] [Abstract][Full Text] [Related]
4. A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia.
Krystal AD; Pizzagalli DA; Smoski M; Mathew SJ; Nurnberger J; Lisanby SH; Iosifescu D; Murrough JW; Yang H; Weiner RD; Calabrese JR; Sanacora G; Hermes G; Keefe RSE; Song A; Goodman W; Szabo ST; Whitton AE; Gao K; Potter WZ
Nat Med; 2020 May; 26(5):760-768. PubMed ID: 32231295
[TBL] [Abstract][Full Text] [Related]
5. The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development.
Krystal AD; Pizzagalli DA; Mathew SJ; Sanacora G; Keefe R; Song A; Calabrese J; Goddard A; Goodman W; Lisanby SH; Smoski M; Weiner R; Iosifescu D; Nurnberger J; Szabo S; Murrough J; Shekhar A; Potter W
Nat Rev Drug Discov; 2018 Dec; 18(1):82-84. PubMed ID: 30591715
[No Abstract] [Full Text] [Related]
6. Approaches to multisite clinical trials: the National Institute of Mental Health perspective.
Lebowitz BD; Vitiello B; Norquist GS
Schizophr Bull; 2003; 29(1):7-13. PubMed ID: 12908657
[TBL] [Abstract][Full Text] [Related]
7. The contributions of Sam Greenhouse to research on psychiatric diagnosis and psychopharmacology.
Katz MM; Berman N
Stat Med; 2003 Nov; 22(21):3291-9. PubMed ID: 14566913
[TBL] [Abstract][Full Text] [Related]
8. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges.
Geerts H; Wikswo J; van der Graaf PH; Bai JPF; Gaiteri C; Bennett D; Swalley SE; Schuck E; Kaddurah-Daouk R; Tsaioun K; Pelleymounter M
CPT Pharmacometrics Syst Pharmacol; 2020 Jan; 9(1):5-20. PubMed ID: 31674729
[TBL] [Abstract][Full Text] [Related]
10. Safety of research into severe and treatment-resistant mood disorders: analysis of outcome data from 12 years of clinical trials at the US National Institute of Mental Health.
Nugent AC; Iadarola ND; Miller FG; Luckenbaugh DA; Zarate CA
Lancet Psychiatry; 2016 May; 3(5):436-42. PubMed ID: 26971192
[TBL] [Abstract][Full Text] [Related]
11. Challenges in developing drugs for pediatric CNS disorders: A focus on psychopharmacology.
Grabb MC; Gobburu JVS
Prog Neurobiol; 2017 May; 152():38-57. PubMed ID: 27216638
[TBL] [Abstract][Full Text] [Related]
12. NIMH initiatives to facilitate collaborations among industry, academia, and government for the discovery and clinical testing of novel models and drugs for psychiatric disorders.
Brady LS; Winsky L; Goodman W; Oliveri ME; Stover E
Neuropsychopharmacology; 2009 Jan; 34(1):229-43. PubMed ID: 18800066
[TBL] [Abstract][Full Text] [Related]
13. Medicine. What are the right targets for psychopharmacology?
Hyman SE; Fenton WS
Science; 2003 Jan; 299(5605):350-1. PubMed ID: 12532001
[No Abstract] [Full Text] [Related]
14. Developing a clinical translational neuroscience taxonomy for anxiety and mood disorder: protocol for the baseline-follow up Research domain criteria Anxiety and Depression ("RAD") project.
Williams LM; Goldstein-Piekarski AN; Chowdhry N; Grisanzio KA; Haug NA; Samara Z; Etkin A; O'Hara R; Schatzberg AF; Suppes T; Yesavage J
BMC Psychiatry; 2016 Mar; 16():68. PubMed ID: 26980207
[TBL] [Abstract][Full Text] [Related]
15. What lies beneath.
Nature; 2014 Mar; 507(7492):273. PubMed ID: 24654275
[No Abstract] [Full Text] [Related]
16. [Multicenter psychopharmacologic research and the data bank].
Cassano GB; Conti L; Massimetti G
Acta Psychiatr Belg; 1983; 83(3):267-81. PubMed ID: 6356790
[TBL] [Abstract][Full Text] [Related]
17. Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS).
Pizzagalli DA; Smoski M; Ang YS; Whitton AE; Sanacora G; Mathew SJ; Nurnberger J; Lisanby SH; Iosifescu DV; Murrough JW; Yang H; Weiner RD; Calabrese JR; Goodman W; Potter WZ; Krystal AD
Neuropsychopharmacology; 2020 Sep; 45(10):1656-1663. PubMed ID: 32544925
[TBL] [Abstract][Full Text] [Related]
18. Evolution of psychopharmacology trial design and analysis: six decades in the making.
Leon AC
J Clin Psychiatry; 2011 Mar; 72(3):331-40. PubMed ID: 21450153
[TBL] [Abstract][Full Text] [Related]
19. Annual meeting of the New Clinical Drug Evaluation Units (NCDEU) program, Psychopharmacology Research Branch, National Institute of Mental Health, 23-25 May 1978, Key Biscayne, Florida.
Psychopharmacol Bull; 1979 Jul; 15(3):22-44. PubMed ID: 493456
[No Abstract] [Full Text] [Related]
20. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.
Green MF; Nuechterlein KH; Kern RS; Baade LE; Fenton WS; Gold JM; Keefe RS; Mesholam-Gately R; Seidman LJ; Stover E; Marder SR
Am J Psychiatry; 2008 Feb; 165(2):221-8. PubMed ID: 18172017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
